0,871  0,004  Caspase 9 stimulant
0,843  0,004  Tubulin antagonist
0,839  0,005  Antineoplastic (lung cancer)
0,831  0,013  Apoptosis agonist
0,823  0,006  Antineoplastic (colorectal cancer)
0,823  0,007  Antineoplastic (breast cancer)
0,820  0,005  Antineoplastic (colon cancer)
0,804  0,005  Antineoplastic (non-small cell lung cancer)
0,802  0,005  Prostate cancer treatment
0,794  0,003  Alpha tubulin antagonist
0,768  0,004  Caspase 3 stimulant
0,743  0,005  NOS2 expression inhibitor
0,742  0,005  Antineoplastic (melanoma)
0,717  0,005  Antimitotic
0,708  0,006  Antineoplastic (cervical cancer)
0,704  0,013  Antileukemic
0,689  0,005  Antineoplastic (multiple myeloma)
0,682  0,005  Antineoplastic (glioma)
0,659  0,005  Antineoplastic (glioblastoma multiforme)
0,649  0,005  Antineoplastic (carcinoma)
0,654  0,012  Antineoplastic (ovarian cancer)
0,650  0,013  Antihypercholesterolemic
0,643  0,008  Antineoplastic (pancreatic cancer)
0,636  0,007  Antineoplastic (brain cancer)
0,612  0,003  Beta tubulin antagonist
0,606  0,005  Antineoplastic (squamous cell carcinoma)
0,587  0,005  Antineoplastic (renal cancer)
0,586  0,005  Hepatoprotectant
0,560  0,005  P-glycoprotein inhibitor
0,562  0,015  Hepatic disorders treatment
0,557  0,019  5 Hydroxytryptamine release stimulant
0,566  0,035  Transcription factor NF kappa B inhibitor
0,544  0,015  CYP2C19 inhibitor
0,515  0,009  Antineoplastic (lymphocytic leukemia)
0,514  0,014  Antipyretic
0,531  0,042  Antineoplastic (solid tumors)
0,491  0,007  Topoisomerase II inhibitor
0,518  0,038  CYP3A4 substrate
0,488  0,012  RNA-directed DNA polymerase inhibitor
0,493  0,020  Chemopreventive
0,504  0,045  TNF expression inhibitor
0,485  0,031  Vasodilator, peripheral
0,460  0,018  Antineoplastic (lymphoma)
0,452  0,019  DNA damaging
0,451  0,019  Amyloid beta aggregation inhibitor
0,443  0,020  Cardiodepressant
0,450  0,027  Antioxidant
0,440  0,025  Vasodilator, coronary
0,437  0,033  Spasmolytic
0,432  0,029  Cytostatic
0,413  0,024  Nitric oxide antagonist
0,403  0,014  Muscle relaxant
0,413  0,027  Hypoxia-inducible factor 1 alpha inhibitor
0,391  0,006  Neurotrophic factor enhancer
0,409  0,027  Free radical scavenger
0,435  0,057  Histamine release inhibitor
0,403  0,026  Tumour necrosis factor alpha release inhibitor
0,387  0,018  Abortion inducer
0,392  0,034  Sensitization
0,369  0,011  Amylase inhibitor
0,391  0,034  CYP3A4 inhibitor
0,368  0,012  Skeletal muscle relaxant
0,380  0,025  Sigma receptor agonist
0,376  0,027  Vasodilator
0,367  0,027  Antineoplastic (small cell lung cancer)
0,345  0,009  Acetylcholinesterase inhibitor
0,349  0,015  VCAM1 expression inhibitor
0,381  0,048  Respiratory analeptic
0,402  0,074  15-Lipoxygenase inhibitor
0,373  0,048  12-Lipoxygenase inhibitor
0,331  0,009  Topoisomerase I inhibitor
0,333  0,013  Liver fibrosis treatment
0,366  0,046  Lipoxygenase inhibitor
0,327  0,019  Melanin inhibitor
0,351  0,043  CYP1A2 inhibitor
0,351  0,043  UGT2B4 substrate
0,331  0,029  Antineoplastic (sarcoma)
0,340  0,042  Proliferative diseases treatment
0,355  0,060  ICAM1 expression inhibitor
0,311  0,017  Lipid peroxidase inhibitor
0,327  0,041  Antineoplastic (liver cancer)
0,306  0,022  Antiseptic
0,321  0,037  DNA synthesis inhibitor
0,334  0,051  Sodium/bile acid cotransporter inhibitor
0,290  0,009  LDLR expression enhancer
0,308  0,031  Anesthetic general
0,292  0,019  Antineoplastic (gastric cancer)
0,288  0,020  Cholinergic
0,304  0,038  Antihypertriglyceridemic
0,304  0,040  Cyclic AMP phosphodiesterase inhibitor
0,267  0,005  Microtubule formation inhibitor
0,285  0,027  Pneumotoxic
0,262  0,018  Antineoplastic (bone cancer)
0,337  0,094  Immunosuppressant
0,340  0,098  Antiprotozoal
0,260  0,018  Heat shock protein 90 antagonist
0,296  0,055  Antiprotozoal (Leishmania)
0,282  0,048  Psychostimulant
0,276  0,044  Antiparkinsonian, rigidity relieving
0,251  0,020  NADPH oxidase inhibitor
0,244  0,015  UGT2B10 substrate
0,307  0,078  AR expression inhibitor
0,235  0,006  Antineoplastic alkaloid
0,301  0,074  Analeptic
0,232  0,009  Dopamine D1 antagonist
0,238  0,024  Genotoxic
0,222  0,013  Cyclooxygenase 3 inhibitor
0,220  0,013  Topoisomerase II alpha inhibitor
0,269  0,063  Antiamyloidogenic
0,219  0,019  Butyrylcholinesterase inhibitor
0,296  0,096  Calcium channel activator
0,271  0,072  UGT1A9 substrate
0,257  0,060  Cytotoxic
0,222  0,025  Carcinogenic, group 1
0,222  0,026  CDC-like kinase 1 inhibitor
0,316  0,123  Antibacterial
0,335  0,143  Alpha-glucosidase inhibitor
0,297  0,109  CYP2C9 substrate
0,292  0,104  Antiprotozoal (Plasmodium)
0,277  0,090  Antineoplastic (osteosarcoma)
0,193  0,008  CDC-like kinase 3 inhibitor
0,256  0,073  Antineoplastic (bladder cancer)
0,294  0,111  Ulceration
0,263  0,085  Radioprotector
0,279  0,101  Apoptosis antagonist
0,230  0,052  Proto-oncogene tyrosine-protein kinase Fyn inhibitor
0,225  0,049  Male reproductive disfunction treatment
0,201  0,031  Antifungal enhancer
0,204  0,034  ATPase inhibitor
0,276  0,107  Cholesterol antagonist
0,228  0,059  Sedative
0,259  0,092  CYP1A2 substrate
0,209  0,043  Antiviral (Herpes)
0,181  0,016  Breast cancer-resistant protein inhibitor
0,185  0,021  Alpha 2c adrenoreceptor antagonist
0,264  0,100  Antifungal
0,197  0,036  Arachidonic acid antagonist
0,187  0,027  Alpha 2b adrenoreceptor antagonist
0,238  0,079  Cardiovascular analeptic
0,161  0,004  Heat shock protein 90 beta antagonist
0,179  0,022  Choleretic
0,173  0,017  Estrogen antagonist
0,254  0,101  CYP2D6 inhibitor
0,226  0,076  Antihypotensive
0,182  0,032  Alkylator
0,171  0,023  Alpha 2 adrenoreceptor antagonist
0,189  0,046  Contraceptive
0,182  0,047  Erectile dysfunction treatment
0,150  0,015  Estrogen receptor beta antagonist
0,190  0,056  Heat shock protein 90 alpha antagonist
0,170  0,036  Antiviral (Hepatitis B)
0,246  0,113  CTGF expression inhibitor
0,143  0,012  Phosphodiesterase 11A inhibitor
0,143  0,012  Phosphodiesterase XI inhibitor
0,133  0,004  Endothelin receptor antagonist
0,154  0,026  Antiviral (Influenza B)
0,165  0,037  DNA intercalator
0,143  0,018  Inducible nitric-oxide synthase inhibitor
0,142  0,019  UGT2B11 substrate
0,149  0,026  Multidrug resistance-associated protein 1 inhibitor
0,182  0,061  Antimutagenic
0,241  0,120  Bone diseases treatment
0,138  0,018  Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor
0,145  0,024  DOPA decarboxylase inhibitor
0,126  0,006  Topoisomerase II beta inhibitor
0,132  0,013  ATPase (Vacuolar H+) inhibitor
0,151  0,033  Antineoplastic (uterine cancer)
0,174  0,057  Antiviral (Influenza A)
0,161  0,045  Adenylate cyclase stimulant
0,182  0,069  UGT2B7 substrate
0,192  0,080  Antiviral (Influenza)
0,221  0,109  Antiosteoporotic
0,143  0,032  Antineoplastic antibiotic
0,134  0,022  Histidine decarboxylase inhibitor
0,188  0,078  CYP2B6 inhibitor
0,165  0,058  Protein kinase stimulant
0,174  0,068  Phobic disorders treatment
0,161  0,062  UGT2B15 substrate
0,166  0,066  Uterine stimulant
0,141  0,043  Papain-like protease (SARS coronavirus) inhibitor
0,102  0,004  Endothelin A receptor antagonist
0,179  0,083  Platelet adhesion inhibitor
0,112  0,015  Postmenopausal disorders treatment
0,116  0,020  HIV-1 integrase (3'-Processing) inhibitor
0,100  0,004  Endothelin B receptor antagonist
0,111  0,019  HIV-1 integrase (Strand Transfer) inhibitor
0,104  0,013  Antitreponemal
0,113  0,022  Phosphodiesterase V inhibitor
0,178  0,089  UGT1A1 substrate
0,112  0,024  Keratolytic
0,090  0,005  Ryanodine receptor antagonist
0,300  0,216  Antiinflammatory
0,207  0,124  Tyrosine 3 hydroxylase inhibitor
0,224  0,142  GST M1-1 substrate
0,128  0,046  Expectorant
0,118  0,036  Calcium antagonist
0,207  0,125  Cardioprotectant
0,168  0,087  Carcinogenic
0,204  0,126  5 Hydroxytryptamine 1E antagonist
0,205  0,128  Chemoprotective
0,225  0,149  Antithrombotic
0,187  0,112  Aldehyde oxidase inhibitor
0,244  0,169  Antipruritic, allergic
0,150  0,077  UGT2B9 substrate
0,142  0,069  Pregnane X receptor agonist
0,110  0,038  SULT1E1 substrate
0,077  0,008  Factor III inhibitor
0,149  0,083  UGT1A3 substrate
0,078  0,012  DNA helicase inhibitor
0,157  0,092  Antipruritic, non-allergic
0,123  0,060  Alcohol dehydrogenase substrate
0,075  0,013  Estrogen receptor alpha agonist
0,093  0,030  Phosphodiesterase 5A inhibitor
0,140  0,079  Acaricide
0,187  0,126  Hypoglycemic
0,129  0,069  Vanilloid 1 agonist
0,096  0,037  Glycine receptor antagonist
0,130  0,072  Skin whitener
0,109  0,051  Anabolic
0,265  0,208  5 Hydroxytryptamine release inhibitor
0,091  0,034  Estrogen receptor alpha antagonist
0,081  0,026  Glutamate (mGluR7) antagonist
0,127  0,073  Cyclooxygenase 1 inhibitor
0,166  0,114  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,096  0,044  Contraceptive male
0,096  0,044  Antiviral (Hepatitis A)
0,088  0,036  CDC25A inhibitor
0,154  0,103  Toxic, respiratory center
0,172  0,124  UGT1A6 substrate
0,118  0,070  Antifungal (Pneumocystis)
0,169  0,122  Antineoplastic enhancer
0,110  0,064  Mucolytic
0,076  0,031  SULT2A1 substrate
0,070  0,026  Estrogen agonist
0,159  0,116  Teratogen
0,122  0,080  Anesthetic
0,066  0,026  Postcoital contraceptive
0,195  0,156  NOS3 expression inhibitor
0,088  0,050  mTOR complex 2 inhibitor
0,081  0,043  Glutamate decarboxylase inhibitor
0,093  0,056  Restless leg syndrome treatment
0,136  0,100  Interferon gamma antagonist
0,108  0,075  Antitussive
0,188  0,154  CYP2D6 substrate
0,079  0,048  Dopamine antagonist
0,092  0,062  Alpha adrenoreceptor antagonist
0,068  0,038  Dopamine D3 antagonist
0,096  0,067  Nitric-oxide synthase inhibitor
0,112  0,084  Contraceptive female
0,117  0,091  Antihemorrhagic
0,133  0,107  Heat shock protein 70 antagonist
0,145  0,120  Pyruvate kinase inhibitor
0,125  0,101  Mutagenic
0,192  0,169  5 Hydroxytryptamine uptake stimulant
0,145  0,122  Succinate dehydrogenase inhibitor
0,066  0,046  Dopamine D2 antagonist
0,143  0,124  Embryotoxic
0,070  0,052  Telomerase inhibitor
0,109  0,091  Antiprotozoal (Amoeba)
0,154  0,137  Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor
0,037  0,019  Tubulin agonist
0,057  0,041  Lipocortins synthesis agonist
0,139  0,125  UDP-glucuronosyltransferase substrate
0,081  0,068  Vanilloid agonist
0,080  0,068  Ornithine decarboxylase inhibitor
0,093  0,082  Antiprotozoal (Toxoplasma)
0,044  0,034  Adenylate cyclase 1 inhibitor
0,076  0,067  Carcinogenic, group 2A
0,073  0,064  5 Hydroxytryptamine 2A antagonist
0,052  0,047  Aromatase inhibitor
0,044  0,039  Phosphodiesterase 6C inhibitor
0,019  0,014  Progesterone receptor B antagonist
0,176  0,171  Transcription factor STAT3 inhibitor
0,039  0,035  Dopamine D2 agonist
0,163  0,159  Lipoprotein disorders treatment
0,110  0,106  Antiparkinsonian, tremor relieving
0,021  0,019  Dopamine D1 agonist
0,065  0,064  Alpha 2a adrenoreceptor antagonist
0,056  0,056  Phosphodiesterase III inhibitor
0,085  0,085  5 Hydroxytryptamine 2 antagonist

